Publisher
Deutscher Arzte-Verlag GmbH
Reference2 articles.
1. Gökbuget N, Dombret H, Bonifacio M, Reichle A, et al.: Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood 5. April 2018; 131 (14): 1522–31. DOI: 10.1182/blood-2017–08–798322. Epub 22. Januar 2018.
2. Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, et al., ECOG-ACRIN-Group: Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med 25. Juli 2024; 391 (4): 320–33. DOI: 10.1056/NEJMoa2312948.